Kenjiro Nagai
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Report on Successful Treatment of Refractory MAC 2 Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.
Journal: Diseases (Basel, Switzerland)
Published: January 17, 2026
Diffuse large B-cell lymphoma successfully treated with amplified natural killer therapy alone: A case report.
Journal: World journal of clinical cases
Published: July 21, 2023
ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease.
Journal: Cancer medicine journal
Published: October 25, 2022
Effectiveness of Amplified Natural Killer (ANK) Therapy for Adult T-cell Leukemia/Lymphoma (ATL) and Future Prospects of ANK Therapy.
Journal: Cancer medicine journal
Published: April 11, 2022
Successful treatment of smouldering Human T cell Leukemia Virus Type1 associated bronchiolitis and alveolar abnormalities with amplified natural killer therapy.
Journal: BMJ case reports
Published: December 08, 2021
Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia.
Journal: Canadian respiratory journal
Published: June 11, 2018
The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis Inpatients.
Journal: Internal medicine (Tokyo, Japan)
Published: January 12, 2018
Modification of oxygen concentrators based on questionnaire survey.
Journal: The clinical respiratory journal
Published: December 01, 2017
ELISA Development for Serum Hemeoxygenase-1 and Its Application to Patients with Acute Respiratory Distress Syndrome.
Journal: Canadian respiratory journal
Published: November 22, 2017
Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis.
Journal: Internal medicine (Tokyo, Japan)
Published: October 13, 2017
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
Journal: The Cochrane database of systematic reviews
Published: February 11, 2017
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.
Journal: Scientific reports
Published: November 17, 2016
Last Updated: 09/26/2026